0001213900-22-035570.txt : 20220628
0001213900-22-035570.hdr.sgml : 20220628
20220628160139
ACCESSION NUMBER: 0001213900-22-035570
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220624
FILED AS OF DATE: 20220628
DATE AS OF CHANGE: 20220628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lis William
CENTRAL INDEX KEY: 0001574558
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39138
FILM NUMBER: 221050046
MAIL ADDRESS:
STREET 1: PORTOLA PHARMACEUTICALS, INC.
STREET 2: 270 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jasper Therapeutics, Inc.
CENTRAL INDEX KEY: 0001788028
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 842984849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 6505491400
MAIL ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: Amplitude Healthcare Acquisition Corp
DATE OF NAME CHANGE: 20190912
4
1
ownership.xml
X0306
4
2022-06-24
0
0001788028
Jasper Therapeutics, Inc.
JSPR
0001574558
Lis William
C/O JASPER THERAPEUTICS, INC.
2200 BRIDGE PKWY, SUITE #102
REDWOOD CITY
CA
94065
1
0
0
0
Voting Common Stock
2022-06-24
4
S
0
24743
2.0220
D
65229
D
Voting Common Stock
2022-06-27
4
S
0
24743
2.0775
D
40486
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.88 to $2.24, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.86 to $2.30, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Executive Chairman of the Board
By: /s/ Jeet Mahal, as Attorney-in-Fact
2022-06-28